Both in Pharmaceuticals
Lexicon Pharmaceuticals vs ArriVent BioPharma
Over the past year LXRX returned 0.0% and AVBP returned −16.7%; their daily moves had a correlation of 0.15.
LXRX 0.0% AVBP −16.7%Growth of $1, one year, split-adjusted
| Metric | LXRX | AVBP |
|---|---|---|
| Price | $1.52 | $16.66 |
| Market cap | $676.3M | $821.5M |
| Today | −7.88% | −0.77% |
| 1 month | −25.3% | −41.3% |
| 6 months | −18.7% | −43.8% |
| Year to date | +32.2% | −17.2% |
| 1 year | −0.7% | −19.0% |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 16.4× | — |
| Net cash | $139.2M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 137.5% |
| Short % of float | 11.4% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).